VERDE BIO HOLDINGS, INC. (APHD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 15K 30K 45K FY18: 41.9K FY19: 0 FY18 FY19

Gross Profit Annual

-1.8K -1.2K -600 0 600 1.2K 1.8K FY20: 0 FY21: -1.7K FY20 FY21

Operating Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY22: -3.2M FY23: -1.6M FY22 FY23

Net Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY22: -3.4M FY23: -1.9M FY22 FY23

Cost of Revenue Annual

0 8K 16K 24K FY18: 23.3K FY19: 0 FY18 FY19

Operating Cash Flow Annual

-1.2M -800K -400K 0 400K 800K 1.2M FY22: -1.2M FY23: -872.2K FY22 FY23

Free Cash Flow Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY22: -4M FY23: -879.2K FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q1 '21: -0.74 Q2 '21: -0.56 Q3 '21: -0.34 Q4 '21: -0.03 Q1 '22: 0.01 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.